Since 1 January 2022 and as of 22 June 2022, the WHO says that 3,413 laboratory confirmed cases of monkeypox and one death have been reported in a total of 50 countries. The majority of these laboratory confirmed cases have been reported in Europe.
While various theories have been put forward to explain the unexpectedly rapid spread of the international outbreak and its accelerated evolution, many people have pointed to the apparent coincidence that it has occurred just as a new generation of smallpox vaccines is in preparation. Because the monkeypox virus is closely related to the virus that causes smallpox, these vaccines are being promoted as a possible means of controlling the outbreak. Notably, therefore, at least one of them utilizes experimental DNA technology. The use of genetic vaccine technologies has been widespread during the COVID-19 pandemic and is associated with serious side effects.
Predictably, therefore, with the United States and the United Kingdom both now reported to be stockpiling smallpox vaccines, it would appear the pharma industry is already gearing up to profit from the outbreak. Déjà vu, anybody?
People Are Hungry: Food Crisis Starts To Bite Across Africa
June 30, 2022Ugandan Health Ministry Says No Child Will Be Vaccinated Against Covid Without Parental Consent
June 30, 2022Monkeypox: WHO Says Outbreak Is ‘Deeply Concerning’ But Not A ‘Public Health Emergency Of International Concern’
News
“The monkeypox outbreak is not yet a global health emergency, the World Health Organization (WHO) has decided – although the director general remains “deeply concerned”.” [Source: news.sky.com]
Comment
Since 1 January 2022 and as of 22 June 2022, the WHO says that 3,413 laboratory confirmed cases of monkeypox and one death have been reported in a total of 50 countries. The majority of these laboratory confirmed cases have been reported in Europe.
While various theories have been put forward to explain the unexpectedly rapid spread of the international outbreak and its accelerated evolution, many people have pointed to the apparent coincidence that it has occurred just as a new generation of smallpox vaccines is in preparation. Because the monkeypox virus is closely related to the virus that causes smallpox, these vaccines are being promoted as a possible means of controlling the outbreak. Notably, therefore, at least one of them utilizes experimental DNA technology. The use of genetic vaccine technologies has been widespread during the COVID-19 pandemic and is associated with serious side effects.
Predictably, therefore, with the United States and the United Kingdom both now reported to be stockpiling smallpox vaccines, it would appear the pharma industry is already gearing up to profit from the outbreak. Déjà vu, anybody?
Dr. Rath Health Foundation
Related posts
Research Suggests Probiotics Plus Vitamin D Supplements May Benefit People With Schizophrenia
Read more